Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-24-022707
Filing Date
2024-06-05
Accepted
2024-06-05 15:50:28
Documents
19
Period of Report
2024-05-15
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 58622
2 ex99-1.htm EX-99.1 246698
3 ex99-2.htm EX-99.2 238212
4 ex99-3.htm EX-99.3 100062
5 ex99-1_001.jpg GRAPHIC 2399
6 ex99-2_001.jpg GRAPHIC 3118
  Complete submission text file 0001493152-24-022707.txt   899597

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE jan-20240515.xsd EX-101.SCH 3006
8 XBRL LABEL FILE jan-20240515_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE jan-20240515_pre.xml EX-101.PRE 22354
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3798
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
JanOne Inc. (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19621 | Film No.: 241021872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)